# FLUOROPHARMA MEDICAL, INC.

FLUOROPHARMA MEDICAL, INC. is a company headquartered in Montclair, NJ, United States.

## Company overview

- **Legal name:** FLUOROPHARMA MEDICAL, INC.
- **Former names in filing history:** Commercial E-Waste Management Inc (2007-06-06 to 2011-03-16)
- **Classification:** Company
- **Industry (SIC):** 2835 — In Vitro & In Vivo Diagnostic Substances
- **Headquarters:** Montclair, NJ, United States
- **Incorporated in:** NV
- **Fiscal year end:** December 31
- **SEC CIK:** 0001402785

## About

FLUOROPHARMA MEDICAL, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001402785, and its reported industry is In Vitro & In Vivo Diagnostic Substances. In 10-K filed on 2017-03-31, it reported net income of USD -2,049,861; total assets of USD 334,760 for the fiscal period ended 2016-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2016 (period ended 2016-12-31)

- **Net income:** -$2.0M (USD -2,049,861)
- **Total assets:** $334,760 (USD 334,760)
- **Cash and equivalents:** $24,723 (USD 24,723)
- **Operating cash flow:** -$880,121 (USD -880,121)

### FY2015 (period ended 2015-12-31)

- **Net income:** -$3.2M (USD -3,163,657)
- **Total assets:** $974,858 (USD 974,858)
- **Cash and equivalents:** $290,847 (USD 290,847)
- **Operating cash flow:** -$2.7M (USD -2,676,889)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

### FY2014 (period ended 2014-12-31)

- **Net income:** -$4.1M (USD -4,130,522)
- **Total assets:** $820,191 (USD 820,191)
- **Cash and equivalents:** $252,145 (USD 252,145)
- **Operating cash flow:** -$3.3M (USD -3,321,419)

### FY2013 (period ended 2013-12-31)

- **Net income:** -$5.6M (USD -5,607,328)
- **Total assets:** $1.9M (USD 1,915,728)
- **Cash and equivalents:** $1.1M (USD 1,143,175)
- **Operating cash flow:** -$3.3M (USD -3,331,797)

## Recent SEC filings

- Form 8-K — filed 2022-06-23 — period 2022-06-22
- Form 10-K — filed 2017-03-31 — period 2016-12-31 — FORM 10-K
- Form 8-K — filed 2017-03-15 — period 2017-01-24 — FORM 8-K
- Form 8-K — filed 2017-03-02 — period 2017-02-24 — FORM 8-K
- Form 8-K — filed 2016-12-29 — period 2016-12-22 — FORM 8-K
- Form 8-K — filed 2016-12-05 — period 2016-11-29 — PRIMARY DOCUMENT
- Form 10-Q — filed 2016-11-14 — period 2016-09-30 — FORM 10-Q
- Form 8-K — filed 2016-11-04 — period 2016-10-31 — FORM 8-K
- Form 8-K — filed 2016-09-30 — period 2016-09-27 — FORM 8-K
- Form 8-K — filed 2016-08-18 — period 2016-08-15 — FORM 8-K
- Form 10-Q — filed 2016-08-15 — period 2016-06-30 — FORM 10-Q
- Form 8-K — filed 2016-07-27 — period 2016-07-22 — FORM 8K

---

Updated: 2026-10-23T20:09:28Z

Canonical page: https://altss.com/profile/fluoropharma-medical-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology